Medicenna Therapeutics Corp (MDNAF)

$1.00 +0.06 (6.13%)
Market Cap 77.83M
Revenue (ttm) 0.00
Net Income (ttm) -18.88M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 54,800
Avg Vol 133,000
Day's Range N/A - N/A
Shares Out 78.22M
Stochastic %K 39%
Beta 1.63
Analysts Strong Sell
Price Target $4.25

Latest News on MDNAF

No data available.